Magnetic Resonance Imaging in a Patient with  a Dual  Chamber Pacemaker by Millar, Lynne Martina et al.
Hindawi Publishing Corporation
Case Reports in Medicine
Volume 2010, Article ID 292071, 3 pages
doi:10.1155/2010/292071
Case Report
Magnetic ResonanceImagingin a Patientwith
aDual ChamberPacemaker
Lynne Martina Millar,1 Andrew GeorgeRobinson,2 MauriceThomasO’Flaherty,2
Niall Eames,2 Nicola Johnston,1 and GaryHeyburn2
1Department of Cardiology, Royal Victoria Hospital, 274 Grosvenor Road, Belfast BT12 6BA, Northern Ireland
2Department of Trauma and Orthopaedics, Royal Victoria Hospital, 274 Grosvenor Road,
Belfast BT12 6BA, Northern Ireland
Correspondence should be addressed to Lynne Martina Millar, lynnemillar@doctors.org.uk
Received 13 August 2010; Revised 5 November 2010; Accepted 3 December 2010
Academic Editor: Peter P. Karpawich
Copyright © 2010 Lynne Martina Millar et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
Having a pacemaker has been seen an absolute contraindication to having an MRI scan. This has become increasingly diﬃcult in
clinicalpractice asinsertionofpacemakersandimplantablecardiacdeﬁbrillatorsisatanalltimehigh.Hereweoutlineacasewhere
a71-year-old malepatient withapermanent pacemakerneeded tohaveanMRI scantoascertain theaetiology ofhisconditionand
help guide further management. Given this clinical dilemma, an emergency clinical ethics consultation was arranged. As a result
the patient underwent an MRI scan safely under controlled conditions with a consultant cardiologist and radiologist present. The
results of the MRI scan were then able to tailor further treatment. This case highlights that in certain conditions an MRI can be
performed in patients with permanent pacemakers and outlines the role ofclinical ethics committees in complex medical decision
making.
1.Introduction
Magnetic resonance imaging (MRI) is the gold standard
imaging modality for the investigation of suspected intracra-
nial or musculoskeletal pathology with 30 million MRI scans
being performed per annum worldwide [1]. It allows excel-
lent soft tissue delineation with minimal contrast toxicity
and no radiation exposure. In parallel to the increasing use
of MRI is the increase in the use of cardiac devices such
as pacemakers and implantable cardiac deﬁbrillators. Each
year 80,000 patients in the United States undergo pacemaker
insertion [2]. In the past having a pacemaker in situ was
seen as an absolute contraindication to having an MRI scan.
In more recent years there have been a limited number of
trials which have shown that in certain cases a patient with a
pacemaker can undergo an MRI scan.
HerewereportacaseofapatientwhounderwentanMRI
scan with a pacemaker in situ and explore the use of clinical
ethics committees in medical decision making.
2.Case Report
A 71-year-old retired architect presented with an 18-month
history of intermittent headaches, diﬃculty in swallowing,
and neck pain. He did not suﬀer any recent weight loss.
Although he was not pacemaker dependent, he previously
had a permanent pacemaker inserted for symptomatic sinus
bradycardia fouryearspreviously.Otherpastmedical history
included transurethral resection of the prostate. He took no
regular medications but had been using nonsteroidal anti-
inﬂammatory drugs as analgesia for his neck pain. Examina-
tion of the central and peripheral neurological systems was
normal. He had a slight decrease in global neck movements
due to pain at the extremes of motion. Plain x-rays of the
cervical spine showed some mild degenerative changes and
generalised osteopenia but few other abnormalities.
Computed tomography (CT) scanning of the brain and
cervical spine identiﬁed extensive destruction of the base
of the skull centred on the clivus with abnormality of the2 Case Reports in Medicine
occipitocervical junction. It was felt that these appearances
were possibly due to metastases or multiple myeloma. A CT
scanofthe chest, abdomen,and pelvis was performed butno
signiﬁcant abnormality was detected. A bone scan conﬁrmed
a solitary lesion at the base of the skull. Bence Jones proteins
were negative and globulins were within the normal range.
Thyroid function and prostate speciﬁc antigen were normal.
A full-body positron emission tomography (PET) scan did
not identify any signiﬁcant abnormalities.
Aclinicaldilemmathereforeexisted.Ifthiswasaprimary
tumour of the brain with bony destruction, the prognosis
may be very guarded and major surgery might not be
appropriate. Alternatively if the tumour originated from
the pituitary gland, surgical treatment may be possible and
potentially curable.
Given the instability of the occipitocervical junction,
occipitocervical fusion of C2/C3/C4 to the occiput was felt
to be necessary in the ﬁrst instance. After informed consent
was obtained this was performed without complication.
After this, it was felt that an MRI scan was essential
to characterise the lesion and to plan further intervention.
The radiology department staﬀ were clearly apprehensive to
proceed with an investigation which they felt could poten-
tially have fatal consequences. They had never conducted
an MRI scan in a patient with a pacemaker and therefore
were keen to seek advice on the ethics of carrying out
such a procedure. Therefore an emergency clinical ethics
consult was arranged. The emergency ethics consult covered
a number of key areas including the eﬀect of turning oﬀ the
pacemaker on the patient and the eﬀect of an MRI scan on
the pacemaker with the possible need for urgent pacemaker
replacement. The possibility of damage to the MRI scanner
was also considered as well as associated health and safety
issues to radiology staﬀ. Alternative imaging modalities
were discussed as was the evidence base available for MRI
scanning of patients with pacemakers in situ. It was felt there
was no suitable alternative imaging modality to MRI. The
patient was counselled regarding the risks involved and the
reasons as to why it was felt necessary. The patient’s medical
team felt the ethical input greatly clariﬁed their thinking.
Therefore after informed consent, an MRI scan was
organised. The MRI scanner that was used was a Phillips
Achivea with a static ﬁeld strength of 1.5Tesla. The patient’s
pacemaker was a Medtronic pacemaker in DDD mode set at
60–150bpm. There was a bipolar atrial lead and a unipolar
ventricularlead. Underthe direct supervision ofa consultant
cardiologist the pacemaker was turned to OAO mode. The
pacing check prior to the MRI showed pacing parameters
and battery voltage within the normal range. The patient’s
observations including blood pressure, heart rate, oxygen
saturation, and ECG monitoring were normal throughout
the MRI. The patient’s intrinsic rhythm was sinus rhythm
and it remained unchanged throughout. The MRI sequences
included sagittal T1, axial T2, axial T2 FLAIR, axial, and
sagittal T1 postgadolinium. The pacing parameters were
checked after the MRI, and they were unchanged from the
pre-MRI parameters. There was no increased impedence
and the thresholds were the same. The pacemaker was then
reset to pre-MRI settings. After MRI there was no raise
in cardiac troponin levels. There was no apparent eﬀect of
the pacemaker on the MRI scanner, and the MRI images
produced were of good quality.
The MRIrevealeddestructionof theskullbase with asig-
niﬁcant loss of the structural integrity of the occipitocervical
junction. It revealed that the tumour appeared to be arising
from the medulla of the skull base and it was potentially
treatable. The patient then underwent an anterior approach
to the skull base transorally. Samples revealed tissue in
keepingwith a plasmacytoma, and haematological treatment
was commenced with the patient to date recovering well.
This case highlights two important points: ﬁrstly that a
pacemaker may not be an absolute contraindication to MRI
scanning and secondly the important role of Clinical Ethics
Committees in diﬃcult medical decisions like this one.
3.Discussion
The evidence around pacemakers being a contraindication
to MRI is controversial. Some of the earlier lines of evidence
is gathered anecdotally from a few patients who died after
an MRI scan and in vitro studies performed using older
pacemakertechnologyandleads.Withinthelastdecadethere
have been a small number of trials that have demonstrated
pacemaker patients undergoing MRI scanning safely. The
risks associated with performing an MRI in a patient
with a pacemaker include motion, dislocation, changes to
programming,changesinthepacemakercomponentscaused
by static/pulsed magnetic ﬁeld, and interference of time-
varying gradient magnetic ﬁeld with pacemaker function
which mimics intrinsic cardiac activity and heating [1, 3].
We know of at least 10 known cases of deaths related to
MRI scanning in patients with pacemaker in situ during the
late 1980s [4]. Inrich et al. searched for all the cases reported
in Germany during 1992–2001. They discovered six fatalities
for which the German public prosecutor had ordered
postmortem examinations on. These MRI scans had been
performed in private radiology practices for neurosurgical
or orthopaedic reasons but there did not appear to be any
cardiac monitoring during the procedure. The postmortem
results on the 3 of the cases concluded that the underlying
causeofdeathwaspresumedventricularﬁbrillation[5].Both
Roguin et al. [6]a n dM a r t i ne ta l .[ 7] strongly recommend
a physician competent in pacing programming should be
present during the procedure. For these reasons we carefully
monitored our patient’s ECG recording and vital signs
during the MRI and had a consultantcardiologist present for
the procedure.
Some of the risks of MRI scans in patients with
pacemakers will now be explored in further detail. One of
the concerns regarding MRI scans in those with pacemakers
is the potential forlead heating. Sommeret al. found that the
temperature increase was related to the speciﬁc absorption
rate (SAR) with 8.9◦C at 0.6W/kg and an increase of 23.5◦C
with an SAR of 1.3W/kg. The increase was more marked
when the lead loop was placed near/at the centre of the
body coil [2]. There is also the potential for a pacemaker toCase Reports in Medicine 3
undergo electrical reset. Som m e re ta l .f o u n dt h a t7o ft h e
115 MRI scans performed were found to have gone through
electrical reset although this was not found to be clinically
signiﬁcant [8]. Roguin et al. found that a third of their
pacemakers also went through electrical reset but these were
all of the same model [6]. This could lead to potential brad-
yarrhythmias or inadequate pacemaker function in those
who are pacemakerdependent. For this reason it makes MRI
scans much more dangerous in these patients. In our patient
we turned the pacemaker to OAO mode thus preventing
potential arrhythmias. Reprogramming the pacemaker as we
did to “therapy oﬀ” in nonpacemaker dependent patients is
recommended by Roguin et al. [6]; however, Martin et al.
feel this is unnecessary as the pacemaker will automatically
enter asynchronous mode in the static magnetic ﬁeld [7].
Reduction in battery voltage had also been reported. One
study investigating MRI scans at ﬁeld strengths of 0.5Tesla
(T) found that there was reduction in battery voltage but
this returned normal at three-month review [2]w h e r e a st h e
same author found in a diﬀerent study at 1.5T that this
was statistically signiﬁcant [8]. However it was felt that the
changes were minor enough not to aﬀect the longevity of the
pacemaker dramatically [8]. One could argue that providing
battery voltage was checked after an MRI scan; this alone
would not preclude the examination. In our patient battery
voltage remained unchanged before and after MRI scan.
4.ClinicalEthicsCommittees
This case outlines the important role that Clinical Ethics
Committees (CEC) can have in diﬃcult medical deci-
sion making. Ethical committees have been established for
decades within the United States; however these are new
phenomena within the UK [9]. As a result some clinical staﬀ
may not be aware of their existence. They provide education
and training, policy formation, and consultation on diﬃcult
cases. They canprovide animpartial body which canprovide
guidance and advice to physicians. In this case there was
obvious clinical dilemma for which there was no clear
solution. The involvement of the CEC was not to provide
legal cover but to ensure the decision making followed
a logical ethical framework. This was an extraordinary
event for the teams involved, and all parties welcomed the
involvement of the committee and the reassurance that came
from their involvement.
5.Conclusion
This paper outlines a case where a patient with a dual
chamber pacemaker successfully underwent an MRI scan at
1.5T without complication. It demonstrates the support a
clinical ethics committee can provide to physicians when
they are faced with an ethical dilemma. Although this paper
does not endorse the routine use of MRI scans in patients
with pacemakers, it merely highlights it may be possible in
controlled conditions. With pacemaker insertion being at an
all-time high this may become more frequent in the future.
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